Profound Medical Corp.
PRN.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -48.27% | -14.82% | 0.84% | -7.60% | 3.50% |
| Total Depreciation and Amortization | -13.36% | -7.14% | 5.03% | 75.72% | 59.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -92.50% | -- |
| Total Other Non-Cash Items | -27.58% | -51.15% | -57.53% | -49.15% | -48.25% |
| Change in Net Operating Assets | 361.85% | 66.74% | 379.69% | 645.51% | 129.36% |
| Cash from Operations | -51.83% | -24.36% | -0.38% | -11.31% | 4.10% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 8.82% | -65.76% | -187.84% | -178.59% | -153.28% |
| Issuance of Common Stock | 70.90% | 69.15% | 2,228.62% | 760.90% | 710.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -63.31% | -63.31% | -- | -1,147.65% | -1,147.65% |
| Cash from Financing | 78.26% | 69.90% | 2,896.78% | 110.13% | 108.96% |
| Foreign Exchange rate Adjustments | 120.04% | -319.21% | -735.83% | -412.80% | -2,391.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.48% | 391.19% | 241.35% | 48.33% | 62.78% |